Software mpMR/US fusion, cognitive, and in-bore biopsy: a comparative analysis of prostate cancer detection
International Urology and Nephrology · 2025
DOI: 10.1007/s11255-025-04736-3 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Vladislav Petov und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Urology and Reproductive Health, Sechenov University, Bolshaya Pirogovskaya St. 2-1, 119435, Moscow, Russia. vladislav.s.petov@gmail.co…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Image-Guided Biopsy, Multiparametric Magnetic Resonance Imaging, Software. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Three MR-targeted biopsy (MR-TB) techniques-software fusion (FUS-TB), cognitive (COG-TB), and in-bore (IB-TB)-are considered comparable by EAU guidelines, although recommendations remain weak. This study aimed to compare detection rates of clinically significant (csPCa), insignificant (cisPCa), and overall prostate cancer (PCa). MATERIALS AND METHODS: This prospective, non-randomized, controlled bicentric study (2019-2024) included biopsy-naïve and previously negative biopsy patients with suspected PCa (PSA ≥ 2 ng/mL, TRUS lesion, positive DRE and PI-RADSv2.1 score ≥ 3). FUS-TB was performed transperineally (3-5 cores) with template mapping biopsy (TPMB; > 20 cores), while COG-TB and IB-TB were performed transrectally (3-5 and 2-3 cores, respectively). COG-TB was combined with standard biopsy (TRUS-GB; 8-12 cores). CsPCa was defined as ISUP grade group ≥ 2. RESULTS: In total, 481 patients were enrolled: 334 underwent FUS-TB + TPMB, 102-COG-TB + TRUS-GB, and 45-IB-TB. PCa detection was similar among groups: FUS-TB (43.4%), COG-TB (42.1%), and IB-TB (40.0%) (p = 0.89). CsPCa detection was also comparable: 23.1%, 30.3%, and 35.5%, respectively (p = 0.09). Subgroup analysis by PI-RADS and multivariable logistic regression confirmed no significant differences in csPCa detection. IB-TB yielded the lowest cisPCa detection (4.4%, p < 0.01). Adding systematic biopsy to FUS-TB and COG-TB resulted in non-significant increases in csPCa detection (+ 6.6%, p = 0.054; + 4.0%, p = 0.55). There were not considerable differences in positive core proportion (p = 0.76), maximum cancer core length (MCCL) (p = 0.08), or ISUP concordance (p = 0.2). CONCLUSION: MR-TB techniques demonstrate comparable csPCa detection after adjustment. IB-TB may reduce overdiagnosis due to lower cisPCa detection rates. Systematic biopsy provides limited additional value, but all results should be interpreted with caution given the study's design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Urology and Reproductive Health, Sechenov University, Bolshaya Pirogovskaya St. 2-1, 119435, Moscow, Russia. vladislav.s.petov@gmail.com.
- SBI of the Rostov Region Clinical and Diagnostic Center Zdorovie, Rostov-On-Don, Russia.
- Institute for Clinical Medicine, Sechenov University, Moscow, Russia.
- Institute for Urology and Reproductive Health, Sechenov University, Bolshaya Pirogovskaya St. 2-1, 119435, Moscow, Russia.
- Department of Radiology, University Clinical Hospital №2, Sechenov University, Moscow, Russia.
- Federal State Budgetary Institution, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia.
Zitieren
APA
Petov, V., Badyan, K., Gredzhev, V., Khalidis, E., Danilov, S., Ermolaev, A., Redkin, V., Chernov, Y., Chinenov, D., Ganzha, T., Rzayev, R., Timofeeva, E., Fokin, I., Enikeev, M., Krupinov, G., Aboyan, I., & Amosov, A. (2025). Software mpMR/US fusion, cognitive, and in-bore biopsy: a comparative analysis of prostate cancer detection. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04736-3
Vancouver
Petov V, Badyan K, Gredzhev V, Khalidis E, Danilov S, Ermolaev A, et al. Software mpMR/US fusion, cognitive, and in-bore biopsy: a comparative analysis of prostate cancer detection. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04736-3
BibTeX
@article{Petov2025,
author = {Petov, Vladislav and Badyan, Konstantin and Gredzhev, Vitaliy and Khalidis, Elina and Danilov, Sergey and Ermolaev, Anton and Redkin, Vladimir and Chernov, Yaroslav and Chinenov, Denis and Ganzha, Timur and Rzayev, Ramin and Timofeeva, Ekaterina and Fokin, Igor and Enikeev, Michael and Krupinov, German and Aboyan, Igor and Amosov, Alexander},
title = {Software mpMR/US fusion, cognitive, and in-bore biopsy: a comparative analysis of prostate cancer detection},
journal = {International Urology and Nephrology},
year = {2025},
doi = {10.1007/s11255-025-04736-3}
}
EUVIMED